DDX3, a potential target for cancer treatment

por Bol, Guus Martinus, Xie, Min, Raman, Venu
Publicado 2015

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3

por Xie, Min, Vesuna, Farhad, Botlagunta, Mahendran, Bol, Guus Martinus, Irving, Ashley, Bergman, Yehudit, Hosmane, Ramachandra S., Kato, Yoshinori, Winnard, Paul T., Raman, Venu
Publicado 2015